The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural features in eukaryotic mRNAs that modulate the initiation of translation.
Kozak, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54860-2 · Cited by 1,836
Haseloff, J., Siemering, K. R., Prasher, D. C., & Hodge, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2122 · Cited by 1,322
Hemesath, T. J., Steingrímsson, E., McGill, G., Hansen, M. J., Vaught, J., Hodgkinson, C. A., Arnheiter, H., Copeland, N. G., Jenkins, N. A., & Fisher, D. E. (1994) · Genes & Development · doi:10.1101/gad.8.22.2770 · Cited by 673
Beckmann, H., Su, L. K., & Kadesch, T. (1990) · Genes & Development · doi:10.1101/gad.4.2.167 · Cited by 457
Alveolar soft-part sarcoma. A clinico-pathologic study of half a century
Lieberman, P. H., Brennan, M. F., Kimmel, M., Erlandson, R. A., Garin-Chesa, P., & Flehinger, B. Y. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<1::aid-cncr2820630102>3.0.co;2-e · Cited by 442
The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway
Hofmann, K. (1996) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(96)30015-7 · Cited by 404
Clark, J., Lu, Y.-J., Sidhar, S. K., Parker, C., Gill, S., Smedley, D., Hamoudi, R., Linehan, W. M., Shipley, J., & Cooper, C. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201394 · Cited by 344
Hua, X., Liu, X., Ansari, D. O., & Lodish, H. F. (1998) · Genes & Development · doi:10.1101/gad.12.19.3084 · Cited by 283
Weterman, M. A. J., Wilbrink, M., & van Kessel, A. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15294 · Cited by 206
Hua, X., Miller, Z. A., Wu, G., Shi, Y., & Lodish, H. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13130 · Cited by 152
Cited by
The impact of translocations and gene fusions on cancer causation
Mitelman, F., Johansson, B., & Mertens, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2091 · Cited by 1,400
Self-citationMITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
Srigley, J. R., Delahunt, B., Eble, J. N., Egevad, L., Epstein, J. I., Grignon, D., Hes, O., Moch, H., Montironi, R., Tickoo, S. K., et al. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318299f2d1 · Cited by 1,047
Self-citationNapolitano, G., & Ballabio, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.146365 · Cited by 845
Melanocytes and the Microphthalmia Transcription Factor Network
Steingrímsson, E., Copeland, N. G., & Jenkins, N. A. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.092717 · Cited by 771
The Lysosome as a Regulatory Hub
Perera, R. M., & Zoncu, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125125 · Cited by 660
Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma
Argani, P., Antonescu, C. R., Illei, P. B., Lui, M. Y., Timmons, C. F., Newbury, R., Reuter, V. E., Garvin, A. J., Perez-Atayde, A. R., Fletcher, J. A., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61684-7 · Cited by 643
Self-citationNovel YAP1‐TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma
Antonescu, C. R., Le Loarer, F., Mosquera, J., Sboner, A., Zhang, L., Chen, C., Chen, H., Pathan, N., Krausz, T., Dickson, B. C., et al. (2013) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22073 · Cited by 597
Self-citationdeFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M. G. F., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001138 · Cited by 557
“TFE3 is a known fusion partner in papillary renal cell carcinoma [30] and alveolar soft part sarcoma [31].”
BackgroundMalignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions
Argani, P., Aulmann, S., Illei, P. B., Netto, G. J., Ro, J., Cho, H.-Y., Dogan, S., Ladanyi, M., Martignoni, G., Goldblum, J. R., et al. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f17ac0 · Cited by 476
Self-citationTFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress
Raben, N., & Puertollano, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125407 · Cited by 437
The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology
Kawakami, A., & Fisher, D. E. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.9 · Cited by 326
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers
Kauffman, E. C., Ricketts, C. J., Rais-Bahrami, S., Yang, Y., Merino, M. J., Bottaro, D. P., Srinivasan, R., & Linehan, W. M. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.162 · Cited by 313
Tsuda, M., Davis, I. J., Argani, P., Shukla, N., McGill, G. G., Nagai, M., Saito, T., Laé, M., Fisher, D. E., & Ladanyi, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2855 · Cited by 306
Self-citationArgani, P., Laé, M., Hutchinson, B., Reuter, V. E., Collins, M. H., Perentesis, J., Tomaszewski, J. E., Brooks, J. S. J., Acs, G., Bridge, J. A., et al. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146007.54092.37 · Cited by 289
Self-citationAlveolar soft-part sarcoma: a review and update
Folpe, A. L., & Deyrup, A. T. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.031120 · Cited by 284
MiT family translocation renal cell carcinoma
Argani, P. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.003 · Cited by 283
Self-citationMorphologic and Molecular Characterization of Renal Cell Carcinoma in Children and Young Adults
Bruder, E., Passera, O., Harms, D., Leuschner, I., Ladanyi, M., Argani, P., Eble, J. N., Struckmann, K., Schraml, P., & Moch, H. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000131558.32412.40 · Cited by 280
Self-citationRegulation of Glucose Transporter Translocation in Health and Diabetes
Bogan, J. S. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060109-094246 · Cited by 279
Flucke, U., Vogels, R. J., de Saint Aubain Somerhausen, N., Creytens, D. H., Riedl, R. G., van Gorp, J. M., Milne, A. N., Huysentruyt, C. J., Verdijk, M. A., van Asseldonk, M. M., et al. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-131 · Cited by 269
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)
Argani, P., Lui, M. Y., Couturier, J., Bouvier, R., Fournet, J.-C., & Ladanyi, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206686 · Cited by 259
Self-citationTrpkov, K., Hes, O., Williamson, S. R., Adeniran, A. J., Agaimy, A., Alaghehbandan, R., Amin, M. B., Argani, P., Chen, Y.-B., Cheng, L., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00779-w · Cited by 258
Self-citationTranslocation Carcinomas of the Kidney
Argani, P., & Ladanyi, M. (2005) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2005.01.008 · Cited by 236
“ASPL–TFE3 and PRCC–TFE3 fusion transcripts are detected readily by conventional reverse transcriptase polymerase chain reaction (RT-PCR) using appropriate primers, as described in detail elsewhere [10,11,17].”
BackgroundMethodSelf-citationUpdates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00462-9 · Cited by 176
Self-citationMolecular characteristics and therapeutic vulnerabilities across paediatric solid tumours
Jones, D. T. W., Banito, A., Grünewald, T. G. P., Haber, M., Jäger, N., Kool, M., Milde, T., Molenaar, J. J., Nabbi, A., Pugh, T. J., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0169-x · Cited by 161
Martina, J. A., Diab, H. I., Li, H., & Puertollano, R. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1565-8 · Cited by 158
“the characteristic modification found in alveolar soft part sarcoma (ASPS), a tumor that is usually involved in muscle and deep soft tissues of the extremities [74].”
A Comparative Genomic Approach for Identifying Synthetic Lethal Interactions in Human Cancer
Deshpande, R., Asiedu, M. K., Klebig, M., Sutor, S., Kuzmin, E., Nelson, J., Piotrowski, J., Ho Shin, S., Yoshida, M., Costanzo, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3956 · Cited by 64
“This fusion truncates one ASPSCR1 allele, leaving the other allele intact in most cases (28, 29).”
TUG protein acts through a disordered region to organize the early secretory pathway
Parchure, A., Tejada, H., Xi, Z., Kim, Y., Su, M., Yan, Y., Julca-Zevallos, O., Alcázar-Román, A. R., Villemeur, M., Liu, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60691-8 · Cited by 5
Metadata
- Authors
- Ladanyi, M., Lui, M. Y., Antonescu, C. R., Krause-Boehm, A., Meindl, A., Argani, P., Healey, J. H., Ueda, T., Yoshikawa, H., Meloni-Ehrig, A., Sorensen, P. H. B., Mertens, F., Mandahl, N., van den Berghe, H., Sciot, R., Dal Cin, P., & Bridge, J.
- Venue
- Oncogene
- Published
- 2001-01-04
- Volume
- 20
- Issue
- 1
- Pages
- 48-57
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2146355396
- Cited by
- 625
- References
- 23
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.